Vanguard Group Inc Nexalin Technology, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Nexalin Technology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 125,460 shares of NXL stock, worth $432,837. This represents 0.0% of its overall portfolio holdings.
Number of Shares
125,460
Previous 31,780
294.78%
Holding current value
$432,837
Previous $21,000
1542.86%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NXL
# of Institutions
20Shares Held
427KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA107KShares$369,9810.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE55.5KShares$191,3430.81% of portfolio
-
State Street Corp Boston, MA32.3KShares$111,4350.0% of portfolio
-
Drive Wealth Management, LLC Lehi, UT20KShares$69,0000.01% of portfolio
-
Atria Wealth Solutions, Inc. New York, NY17.2KShares$59,4840.0% of portfolio
About Nexalin Technology, Inc.
- Ticker NXL
- Exchange
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 7,279,960
- Market Cap $25.1M